ArticleNeurology2018
Racial/ethnic variation of
Abstract read
In one paragraph
Article in Neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 4 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 4 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- The APOE paradox: divergent genetic influences on hemorrhagic stroke risk-A meta-analysis.Frontiers in stroke · 2026Pooled it
- Role of LDL-C level alteration in increased mortality risks in spontaneous intracerebral hemorrhage patients: Systematic review and meta-analysis.Frontiers in neurology · 2023Pooled it
- Genetic risk of Spontaneous intracerebral hemorrhage: Systematic review and future directions.Journal of the neurological sciences · 2019Pooled it
- Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity: A Meta-analysis.JAMA neurology · 2019Pooled it
- Article
- Association ofStroke and vascular neurology · 2025Article
- Subarachnoid hemorrhage and finger-like projection predict recurrence in patients with lobar intracerebral hemorrhage.Journal of neurology · 2025Article
- Apolipoprotein E genotype is associated with island sign in lobar intracerebral hemorrhage.Frontiers in neurology · 2025Article
- Dental Caries a Risk Factor for Intracerebral Hemorrhage.Cerebrovascular diseases (Basel, Switzerland) · 2024Article
- Genetic considerations in cerebral small vessel diseases.Frontiers in neurology · 2023Review
- Observational
- Lower low-density lipoprotein cholesterol levels are associated with an increased risk of hematoma expansion and ensuing mortality in acute ICH patients.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022Article
- CT-Visible Convexity Subarachnoid Hemorrhage Predicts Early Recurrence of Lobar Hemorrhage.Frontiers in neurology · 2022Article
- Human Galectin-7 GeneFrontiers in molecular neuroscience · 2022Article
- Ethnic and Racial Variation in Intracerebral Hemorrhage Risk Factors and Risk Factor Burden.JAMA network open · 2021Article
- Risk of intracerebral haemorrhage from hypertension is greatest at an early age.European stroke journal · 2021Article
- Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypes.Neurology · 2020Observational
- Article
- A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward.Neuron · 2019Review
- Assessment of Racial Disparities in Biomarkers for Alzheimer Disease.JAMA neurology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Russell P SawyerFrom the Department of Neurology and Rehabilitation Medicine (R.P.S., P.S., J.O., C.J.M., M.L.F., D.W.), University of Cincinnati College of Medicine, OH; Department of Neurology (S.J.K.), Baltimore Veterans Administration Medical Center and University of Maryland School of Medicine, MD; Center for Public Health Genomics and Department of Biostatistical Sciences (C.D.L.), Wake Forest University, Winston-Salem, NC; and Center for Genomic Medicine (C.D.A., J.R.), Massachusetts General Hospital, Boston. sawyerrl@ucmail.uc.edu.
Padmini SekarFrom the Department of Neurology and Rehabilitation Medicine (R.P.S., P.S., J.O., C.J.M., M.L.F., D.W.), University of Cincinnati College of Medicine, OH; Department of Neurology (S.J.K.), Baltimore Veterans Administration Medical Center and University of Maryland School of Medicine, MD; Center for Public Health Genomics and Department of Biostatistical Sciences (C.D.L.), Wake Forest University, Winston-Salem, NC; and Center for Genomic Medicine (C.D.A., J.R.), Massachusetts General Hospital, Boston.
Jennifer OsborneFrom the Department of Neurology and Rehabilitation Medicine (R.P.S., P.S., J.O., C.J.M., M.L.F., D.W.), University of Cincinnati College of Medicine, OH; Department of Neurology (S.J.K.), Baltimore Veterans Administration Medical Center and University of Maryland School of Medicine, MD; Center for Public Health Genomics and Department of Biostatistical Sciences (C.D.L.), Wake Forest University, Winston-Salem, NC; and Center for Genomic Medicine (C.D.A., J.R.), Massachusetts General Hospital, Boston.
Steven J KittnerFrom the Department of Neurology and Rehabilitation Medicine (R.P.S., P.S., J.O., C.J.M., M.L.F., D.W.), University of Cincinnati College of Medicine, OH; Department of Neurology (S.J.K.), Baltimore Veterans Administration Medical Center and University of Maryland School of Medicine, MD; Center for Public Health Genomics and Department of Biostatistical Sciences (C.D.L.), Wake Forest University, Winston-Salem, NC; and Center for Genomic Medicine (C.D.A., J.R.), Massachusetts General Hospital, Boston.
Charles J MoomawFrom the Department of Neurology and Rehabilitation Medicine (R.P.S., P.S., J.O., C.J.M., M.L.F., D.W.), University of Cincinnati College of Medicine, OH; Department of Neurology (S.J.K.), Baltimore Veterans Administration Medical Center and University of Maryland School of Medicine, MD; Center for Public Health Genomics and Department of Biostatistical Sciences (C.D.L.), Wake Forest University, Winston-Salem, NC; and Center for Genomic Medicine (C.D.A., J.R.), Massachusetts General Hospital, Boston.
Matthew L FlahertyFrom the Department of Neurology and Rehabilitation Medicine (R.P.S., P.S., J.O., C.J.M., M.L.F., D.W.), University of Cincinnati College of Medicine, OH; Department of Neurology (S.J.K.), Baltimore Veterans Administration Medical Center and University of Maryland School of Medicine, MD; Center for Public Health Genomics and Department of Biostatistical Sciences (C.D.L.), Wake Forest University, Winston-Salem, NC; and Center for Genomic Medicine (C.D.A., J.R.), Massachusetts General Hospital, Boston.
Carl D LangefeldFrom the Department of Neurology and Rehabilitation Medicine (R.P.S., P.S., J.O., C.J.M., M.L.F., D.W.), University of Cincinnati College of Medicine, OH; Department of Neurology (S.J.K.), Baltimore Veterans Administration Medical Center and University of Maryland School of Medicine, MD; Center for Public Health Genomics and Department of Biostatistical Sciences (C.D.L.), Wake Forest University, Winston-Salem, NC; and Center for Genomic Medicine (C.D.A., J.R.), Massachusetts General Hospital, Boston.
Christopher D AndersonFrom the Department of Neurology and Rehabilitation Medicine (R.P.S., P.S., J.O., C.J.M., M.L.F., D.W.), University of Cincinnati College of Medicine, OH; Department of Neurology (S.J.K.), Baltimore Veterans Administration Medical Center and University of Maryland School of Medicine, MD; Center for Public Health Genomics and Department of Biostatistical Sciences (C.D.L.), Wake Forest University, Winston-Salem, NC; and Center for Genomic Medicine (C.D.A., J.R.), Massachusetts General Hospital, Boston.
Jonathan RosandFrom the Department of Neurology and Rehabilitation Medicine (R.P.S., P.S., J.O., C.J.M., M.L.F., D.W.), University of Cincinnati College of Medicine, OH; Department of Neurology (S.J.K.), Baltimore Veterans Administration Medical Center and University of Maryland School of Medicine, MD; Center for Public Health Genomics and Department of Biostatistical Sciences (C.D.L.), Wake Forest University, Winston-Salem, NC; and Center for Genomic Medicine (C.D.A., J.R.), Massachusetts General Hospital, Boston.
Daniel WooFrom the Department of Neurology and Rehabilitation Medicine (R.P.S., P.S., J.O., C.J.M., M.L.F., D.W.), University of Cincinnati College of Medicine, OH; Department of Neurology (S.J.K.), Baltimore Veterans Administration Medical Center and University of Maryland School of Medicine, MD; Center for Public Health Genomics and Department of Biostatistical Sciences (C.D.L.), Wake Forest University, Winston-Salem, NC; and Center for Genomic Medicine (C.D.A., J.R.), Massachusetts General Hospital, Boston.
Funding
Ethnic/Racial Variation in Intracerebral Hemorrhage (ERICH)U01NS069763 · NINDS · UNIVERSITY OF CINCINNATI · PI ANDERSON, CHRISTOPHER DAVID, DEMEL, STACIE · 2010 to 2024
$34.2MGenetic Analyses of Lipids in Cerebral Hemorrhage and Small Vessel DiseaseK23NS086873 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ANDERSON, CHRISTOPHER DAVID · 2014 to 2018
$951kNINDS NIH HHS K23 NS086873NINDS NIH HHS U01 NS069763
Abstract
objective
methodsThe Ethnic/Racial Variations of Intracerebral Hemorrhage study is a prospective, multicenter case-control study of ICH among white, black, and Hispanic participants. Controls were recruited to match cases based on age, ethnicity/race, sex, and geographic location.
resultsThere were 907 cases of lobar ICH and 2,660 controls with
conclusionIn contrast to Caucasian patients, in which amyloid risk factors predominate in lobar ICH, we found that hypertension was the predominant risk factor for lobar ICH. While
Indexed as
AllelesAgedApolipoprotein E2Cerebral HemorrhageEthnicityFemaleGenetic VariationHumansMaleMiddle AgedRacial GroupsApolipoprotein E2
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.